Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer? ...Middle East

Neoadjuvant chemoradiotherapy can be omitted in low-risk rectal cancer patients without compromising outcomes, but intensified in high-risk patients, new findings suggest. Medscape Medical News

Hence then, the article about risk adapted neoadjuvant chemoradiotherapy in rectal cancer was published today ( Tuesday 27/06/2023 - 09:56 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer? )

Also on site :

• commercetools Kicks Off NRF 2026 - including Updates on Stripe ACS, AI Hub, and Helping Enterprises Stay Discoverable and Shoppable in Agentic Commerce
• inDrive turns to ads and groceries to diversify revenue
• Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates